(Q35533728)

English

Comparison of the effects of intravenous and oral montelukast on airway function: a double blind, placebo controlled, three period, crossover study in asthmatic patients

scientific article published on April 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Comparison of the effects of intravenous and oral montelukast on airway function: a double blind, placebo controlled, three period, crossover study in asthmatic patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

0 references

0 references

author name string

Dockhorn RJ

1

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Baumgartner RA

2

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Leff JA

3

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Noonan M

4

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Vandormael K

5

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Stricker W

6

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Weinland DE

7

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Reiss TF

8

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

language of work or name

0 references

publication date

1 April 2000

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

55

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

260-265

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Montelukast, a potent leukotriene receptor antagonist, causes dose-related improvements in chronic asthma. Montelukast Asthma Study Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1745728

27 July 2018

A comparison between emergency diagnostic and treatment unit and inpatient care in the management of acute asthma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1745728

27 July 2018

Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1745728

27 July 2018

The influence of parasympatholytics on the resolution of acute attacks of asthma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1745728

27 July 2018

Effects of montelukast (MK-0476); a potent cysteinyl leukotriene receptor antagonist, on bronchodilation in asthmatic subjects treated with and without inhaled corticosteroids

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1745728

27 July 2018

Observations on the effects of aerosolized albuterol in acute asthma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1745728

27 July 2018

Pharmacokinetics, bioavailability, and safety of montelukast sodium (MK-0476) in healthy males and females.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1745728

27 July 2018

Emergency room of treatment of asthma. Relationships among therapeutic combinations, severity of obstruction and time course of response

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1745728

27 July 2018

Ontogenetic patterns of thyrotropin-releasing hormone-like material in rat hypothalamus, pancreas, and retina: selective effect of light deprivation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1745728

27 July 2018

Comparative effects of inhaled leukotriene C4, leukotriene D4, and histamine in normal human subjects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1745728

27 July 2018

Leukotrienes: Mediators of Immediate Hypersensitivity Reactions and Inflammation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1745728

27 July 2018

Lung function improvement in asthma with a cysteinylleukotriene receptor antagonist

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1745728

27 July 2018

Evidence for the increase in asthma worldwide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1745728

26 September 2018

A placebo-controlled, dose-ranging study of montelukast, a cysteinyl leukotriene-receptor antagonist. Montelukast Asthma Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/10722763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A controlled trial of the use of single versus combined-drug therapy in the treatment of acute episodes of asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/10722763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Slow-reacting substances, leukotrienes C4 and D4, increase the release of mucus from human airways in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/10722763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of exercise-induced bronchoconstriction by MK-571, a potent leukotriene D4-receptor antagonist

1 reference

https://pubmed.ncbi.nlm.nih.gov/10722763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recovery of Leukotriene E4from the Urine of Patients with Airway Obstruction

1 reference

https://pubmed.ncbi.nlm.nih.gov/10722763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bronchodilation with a potent and selective leukotriene D4 (LTD4) receptor antagonist (MK-571) in patients with asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/10722763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute bronchodilation with an intravenously administered leukotriene D4 antagonist, MK-679

1 reference

https://pubmed.ncbi.nlm.nih.gov/10722763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/10722763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The clinical efficacy of combination nebulized anticholinergic and adrenergic bronchodilators vs nebulized adrenergic bronchodilator alone in acute asthma. Canadian Combivent Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/10722763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systemic corticosteriod rapidly reverses bronchodilator subsensitivity induced by formoterol in asthmatic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/10722763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early parenteral corticosteroid administration in acute asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/10722763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose-related protection of exercise bronchoconstriction by montelukast, a cysteinyl leukotriene-receptor antagonist, at the end of a once-daily dosing interval

1 reference

https://pubmed.ncbi.nlm.nih.gov/10722763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Montelukast for chronic asthma in 6- to 14-year-old children: a randomized, double-blind trial. Pediatric Montelukast Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/10722763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/10722763

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/THORAX.55.4.260

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35533728&oldid=1628831179"